Teva gives up on (former) partner's inhaler; Neos orally disintegrating tablet performs well in Phase III;

> Alexza Pharmaceuticals ($ALXA) is reacquiring the U.S. rights to its Adasuve inhalation powder from Teva ($TEVA). The company aims to find a new partner next year for the product to treat central nervous system conditions. It's delivered into the lungs via the Staccato hand-held inhaler. More

> Neos Therapeutics said its extended-release, orally disintegrating tablet for ADHD performed better than placebo in a Phase III trial. More